Pfizer bounces back from Allergan setback by buying, buying, buying
The drug giant’s point man in Ireland talks about acquisitions, setbacks, prices and Trump
Drugmaker Pfizer abandons plan to split into two
Company’s shares down 1.3% in premarket trading after it says it will not separate
Pfizer blocks its drugs from use in lethal injections
Executions have slowed in recent years in US as drug makers’ prohibition on the use of their drugs takes effect
Pfizer revenue beats expectations on Hospira acquisition
Company had also planned $160bn merger with Allergan but new US rules ended deal
Novartis replaces head of eye care division after profit miss
Company says that fourth-quarter core net income fell 5 per cent to $2.707bn
Pfizer and Allergan will have to find right mix
Integrating two companies with wildly differing corporate cultures will be far from straightforward
Pfizer in merger talks with Botox-maker Allergan
Takeover could offer tax advantages given that Allergan is based in Dublin
AbbVie boosts cancer drug pipeline with Pharmacyclics deal
Company to pay $261.25 per share in cash and stock
ECB move on Greek bonds hits stock markets
Bank of Ireland and CRH down with slight falls also for Aer Lingus and Ryanair
Pfizer to buy Hospira for $15bn to boost copycat drug business
Deal would be Pfizer’s biggest since last year’s failed takeover of AstraZeneca
French plan to push copycat biotech drugs worries Big Pharma
Government introduced measure allowing pharmacists to substitute cheaper versions
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices